Winston-Salem, NC, United States of America

Jeffrey Daniel Schmitt

USPTO Granted Patents = 24 



Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 205(Granted Patents)


Location History:

  • Winston-Salem, NC (US) (2001 - 2014)
  • Asheville, NC (US) (2010 - 2018)

Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Jeffrey Daniel Schmitt: Innovator in Pharmaceutical Development

Introduction: Jeffrey Daniel Schmitt, based in Winston-Salem, NC, is an accomplished inventor with a remarkable record of 24 patents. His work primarily focuses on innovative methods for treating various medical disorders, including cancer and neurodegenerative diseases.

Latest Patents: Among his noteworthy patents, Schmitt has developed methods for treating cancer and other disorders. His patents detail active compounds that inhibit fatty acid synthase, targeting conditions such as cancer, obesity, diabetes, and various infections. Additionally, he has created novel arylvinylazacycloalkane compounds that act as ligands for nAChRs, proving beneficial for treating disorders linked to their dysfunction, particularly in the central nervous system and gastrointestinal system. These compounds hold potential for addressing neurodegenerative disorders like Alzheimer's and Parkinson's disease, along with serving as analgesics for pain management.

Career Highlights: Schmitt has made significant contributions to pharmaceutical research and development, working with notable companies such as Targacept, Inc. His innovative approaches to treatment reflect a deep understanding of complex medical challenges and the application of cutting-edge science.

Collaborations: Throughout his career, Schmitt has collaborated with talented professionals, including Craig Harrison Miller and Gary Maurice Dull. These partnerships have been essential in advancing his research and enhancing the impact of his inventions in the medical field.

Conclusion: Jeffrey Daniel Schmitt exemplifies the spirit of innovation in the pharmaceutical industry. His extensive patent portfolio demonstrates his commitment to improving health outcomes through groundbreaking therapies. As he continues to develop new solutions, Schmitt remains a key figure in the ongoing quest to combat serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…